SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Nabi (NABI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: meg who wrote (11)1/29/1997 6:18:00 PM
From: The BayWatcher   of 354
 
Earnings will be released during the week of 2/17.
I read yesterday's DLJ report closely today and
they note that NABI's HIV drug is not only showing
postive results in neutralizing the HIV virus from
mother to infant but that it is actually showing
postive results, when taken with another drug, in
directly neutralizing the HIV virus. DLJ says
these results will increase NABI's visibility and
its share price. DLJ said they expect NABI to
deliver "solid earnings" (that's their quote, not
mine). I also read a report from First Albany
which rates NABI a BUY and has a target price of
18.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext